Fig. 1: CONSORT diagram of the study reporting screening, randomization and follow-up of ALS patients enrolled in the trial.
From: Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis
Source data are provided as a Source Data file.
